Effect of Different Vaccination Schedules on Excretion of Oral Poliovirus Vaccine Strains
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Inactivated poliovirus vaccine (IPV) is believed to induce significantly lower mucosal immunity than oral poliovirus vaccine (OPV). Most of the data supporting this were generated before enhanced IPV (eIPV) was introduced. Excretion of poliovirus by OPV recipients can be used to assess intestinal immunity. We studied polymerase chain reaction amplification of viral complementary DNA from the stool of children vaccinated with either OPV alone or eIPV. Of first-time OPV recipients, 92% excreted virus after 1 week, and 81% excreted virus after 3 weeks. Prior vaccination with OPV reduced the number to 22% and shortened the duration of virus excretion (to 5% after 3 weeks). Two doses of IPV reduced the number of poliovirus-positive 1-week samples (to 76%), the duration of shedding (to 37% at 3 weeks), and the quantity of excreted virus. This suggests that IPV-vaccinated communities are partially protected from the spread of poliovirus. Further enhancement of IPV potency may lead to even higher levels of mucosal immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Three of these studies also examined the duration of shedding and two found a shorter period of shedding in IPV vaccinated children [17], [19].”
From Systematic Review of Mucosal Immunity Induced by Oral and Inactivated Poliovirus Vaccines against Virus Shedding following Oral Poliovirus Challenge (2012) · cites this paper as [19]
In the citing paper
“Several studies have shown that IPV reduces the duration and rate of virus shedding in immunised individuals compared with unimmunised individuals, although IPV is not effective in preventing PV replication in the gut [69,70].”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [70]
Citations
Cites
Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., et al. (2002) · Science · doi:10.1126/science.1068284 · Cited by 600
Strebel, P. M., Sutter, R. W., Cochi, S. L., Biellik, R. J., Brink, E. W., Kew, O. M., Pallansch, M. A., Orenstein, W. A., & Hinman, A. R. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.568 · Cited by 337
Mucosal Immunity Induced by Enhanced-Potency Inactivated and Oral Polio Vaccines
Onorato, I. M., Modlin, J. F., McBean, A. M., Thoms, M. L., Losonsky, G. A., & Bernier, R. H. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.1.1 · Cited by 246
Martín, J., Dunn, G., Hull, R., Patel, V., & Minor, P. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3001-3010.2000 · Cited by 160
Multiple Genetic Changes Can Occur in the Oral Poliovaccines upon Replication in Humans
Kew, O. M., Nottay, B. K., Hatch, M. H., Nakano, J. H., & Obijeski, J. F. (1981) · Journal of General Virology · doi:10.1099/0022-1317-56-2-337 · Cited by 148
Polio eradication: the OPV paradox
Dowdle, W. R., De Gourville, E., Kew, O. M., Pallansch, M. A., & Wood, D. J. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.401 · Cited by 144
Recombinant Vaccine–Derived Poliovirus in Madagascar
Rousset, D., Rakoto-Andrianarivelo, M., Razafindratsimandresy, R., Randriamanalina, B., Guillot, S., Balanant, J., Mauclère, P., & Delpeyroux, F. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0907.020692 · Cited by 138
Khetsuriani, N., Prevots, D. R., Quick, L., Elder, M. E., Pallansch, M., Kew, O., & Sutter, R. W. (2003) · The Journal of Infectious Diseases · doi:10.1086/379791 · Cited by 110
Cherkasova, E., Laassri, M., Chizhikov, V., Korotkova, E., Dragunsky, E., Agol, V. I., & Chumakov, K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633511100 · Cited by 101
Self-citationDunn, G., Begg, N. T., Cammack, N., & Minor, P. D. (1990) · Journal of Medical Virology · doi:10.1002/jmv.1890320205 · Cited by 94
Cited by
Polio vaccination: Past, present and future
Bandyopadhyay, A. S., Garon, J., Seib, K., & Orenstein, W. A. (2015) · Future Microbiology · doi:10.2217/fmb.15.19 · Cited by 276
Hird, T. R., & Grassly, N. C. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002599 · Cited by 221
“Three of these studies also examined the duration of shedding and two found a shorter period of shedding in IPV vaccinated children [17,19].”
BackgroundExpert Review on Poliovirus Immunity and Transmission
Duintjer Tebbens, R. J., Pallansch, M. A., Chumakov, K. M., Halsey, N. A., Hovi, T., Minor, P. D., Modlin, J. F., Patriarca, P. A., Sutter, R. W., Wright, P. F., et al. (2013) · Risk Analysis · doi:10.1111/j.1539-6924.2012.01864.x · Cited by 109
Self-citationPoliovirus Vaccine–Inactivated
Vidor, E. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00047-x · Cited by 93
Pliaka, V., Kyriakopoulou, Z., & Markoulatos, P. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.28 · Cited by 85
Famulare, M., Chang, S., Iber, J., Zhao, K., Adeniji, J. A., Bukbuk, D., Baba, M., Behrend, M., Burns, C. C., & Oberste, M. S. (2016) · Journal of Virology · doi:10.1128/jvi.01532-15 · Cited by 73
Poliovirus vaccine—inactivated
Vidor, E. J., & Plotkin, S. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00034-3 · Cited by 80
Self-citationMucosal Immunity after Vaccination with Monovalent and Trivalent Oral Poliovirus Vaccine in India
Grassly, N. C., Jafari, H., Bahl, S., Durrani, S., Wenger, J., Sutter, R. W., & Aylward, R. B. (2009) · The Journal of Infectious Diseases · doi:10.1086/605330 · Cited by 77
Parker, E. P. K., Molodecky, N. A., Pons-Salort, M., O’Reilly, K. M., & Grassly, N. C. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1052800 · Cited by 75
Waning Intestinal Immunity After Vaccination With Oral Poliovirus Vaccines in India
Grassly, N. C., Jafari, H., Bahl, S., Sethi, R., Deshpande, J. M., Wolff, C., Sutter, R. W., & Aylward, R. B. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis241 · Cited by 72
Poliovirus vaccine-inactivated
Plotkin, S. A., & Vidor, E. J. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50029-5 · Cited by 70
Self-citationPoliovirus vaccination options for achieving eradication and securing the endgame
Estívariz, C. F., Pallansch, M. A., Anand, A., Wassilak, S. G., Sutter, R. W., Wenger, J. D., & Orenstein, W. A. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.05.007 · Cited by 66
Wanted, dead or alive: New viral vaccines
Amanna, I. J., & Slifka, M. K. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.08.008 · Cited by 66
Evaluation of Response Scenarios to Potential Polio Outbreaks Using Mathematical Models
Thompson, K. M., Tebbens, R. J. D., & Pallansch, M. A. (2006) · Risk Analysis · doi:10.1111/j.1539-6924.2006.00843.x · Cited by 66
Cosavirus Infection in Persons with and without Gastroenteritis, Brazil
Stöcker, A., Souza, B. F. D. C. D., Ribeiro, T. C. M., Netto, E. M., de Araújo, L. O., Corrêa, J. I., Almeida, P. S., de Mattos, Â. P., Ribeiro, H. D. C., Pedral-Sampaio, D., et al. (2012) · Emerging infectious diseases · doi:10.3201/eid1804.111415 · Cited by 63
Isolation of Sabin-Like Polioviruses from Wastewater in a Country Using Inactivated Polio Vaccine
Zurbriggen, S., Tobler, K., Abril, C. E., Diedrich, S., Ackermann, M., Pallansch, M. A., & Metzler, A. E. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.02764-07 · Cited by 59
Randomized Trial of Inactivated and Live Polio Vaccine Schedules in Guatemalan Infants
Asturias, E. J., Dueger, E. L., Omer, S. B., Melville, A., Nates, S. V., Laassri, M., Chumakov, K., & Halsey, N. A. (2007) · The Journal of Infectious Diseases · doi:10.1086/520546 · Cited by 56
Self-citationThe global introduction of inactivated polio vaccine can circumvent the oral polio vaccine paradox
Heinsbroek, E., & Ruitenberg, E. J. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.095 · Cited by 55
Enteric Viruses in Surface Waters from Argentina: Molecular and Viable-Virus Detection
Masachessi, G., Pisano, M. B., Prez, V. E., Martínez, L. C., Michelena, J. F., Wassaf, M. G. M., Giordano, M. O., Isa, M. B., Pavan, J. V., Welter, A., et al. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.02327-17 · Cited by 54
Grassly, N. C., Jafari, H., Bahl, S., Durrani, S., Wenger, J., Sutter, R. W., & Bruce Aylward, R. (2010) · The Journal of Infectious Diseases · doi:10.1086/651952 · Cited by 50
Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis
Ciapponi, A., Bardach, A., Ares, L. R., Glujovsky, D., Cafferata, M. L., Cesaroni, S., & Aikant, B. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011260.pub2 · Cited by 45
Assessing the stability of polio eradication after the withdrawal of oral polio vaccine
Famulare, M., Selinger, C., McCarthy, K. A., Eckhoff, P. A., & Chabot‐Couture, G. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2002468 · Cited by 41
Summary of Excreted and Waterborne Viruses
Rusiñol, M., & Gironés, R. (2018) · Michigan State University eBooks · doi:10.14321/waterpathogens.19 · Cited by 39
Shulman, L. M., Martín, J. E.-S., Sofer, D., Burns, C. C., Manor, Y., Hindiyeh, M. Y., Gavrilin, E., Wilton, T., Moran‐Gilad, J., Gamzo, R., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu1136 · Cited by 36
for the POG group, Yaari, R., Kaliner, E., Grotto, I., Katriel, G., Moran‐Gilad, J., Sofer, D., Mendelson, E., Miller, E., Huppert, A., et al. (2016) · BMC Medicine · doi:10.1186/s12916-016-0637-z · Cited by 36
Kimman, T. G., & Boot, H. J. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70603-x · Cited by 36
de Silva, R., Gunasena, S., Ratnayake, D., Wickremesinghe, G. D., Kumarasiri, C., Pushpakumara, B. A. W., Deshpande, J. M., Kahn, A.-L., & Sutter, R. W. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.035 · Cited by 35
The Fight against Poliovirus Is Not Over
Mbani, C. J., Nekoua, M. P., Moukassa, D., & Hober, D. (2023) · Microorganisms · doi:10.3390/microorganisms11051323 · Cited by 34
“Several studies have shown that IPV reduces the duration and rate of virus shedding in immunised individuals compared with unimmunised individuals, although IPV is not effective in preventing PV replication in the gut [69,70].”
BackgroundSwartz, T. A., Green, M. S., Handsher, R., Sofer, D., Cohen‐Dar, M., Shohat, T., Habib, S. A., BARAK, E., Dror, Z., Somekh, E., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.12.021 · Cited by 33
Troy, S. B., Ferreyra-Reyes, L. D., Huang, C., Mahmud, N., Lee, Y.-J., Canizales‐Quintero, S., Flaster, H. V., Báez-Saldaña, R., García‐García, L., & Maldonado, Y. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02524-10 · Cited by 33
Contextualizing Wastewater-Based surveillance in the COVID-19 vaccination era
Armas, F., Chandra, F., Lee, W. L., Gu, X., Chen, H., Xiao, A., Leifels, M., Wuertz, S., Alm, E. J., & Thompson, J. R. (2022) · Environment International · doi:10.1016/j.envint.2022.107718 · Cited by 31
Inferring the reproduction number using the renewal equation in heterogeneous epidemics
Green, W. D., Ferguson, N. M., & Cori, A. (2022) · Journal of The Royal Society Interface · doi:10.1098/rsif.2021.0429 · Cited by 29
Use of inactivated poliovirus vaccine for poliovirus outbreak response
Bandyopadhyay, A. S., Cavestany, R. L., Blake, I. M., Macklin, G., Cooper, L., Grassly, N. C., Nery, A. L. M. D. S., & Mach, O. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00505-4 · Cited by 29
Laassri, M., Lottenbach, K. R., Belshe, R. B., Rennels, M. B., Plotkin, S. A., & Chumakov, K. (2006) · The Journal of Infectious Diseases · doi:10.1086/503366 · Cited by 29
Self-citationMangal, T. D., Aylward, R. B., & Grassly, N. C. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt203 · Cited by 28
Circulating Vaccine Derived Polio Viruses and their Impact on Global Polio Eradication
Wagner, B. G., & Earn, D. J. D. (2007) · Bulletin of Mathematical Biology · doi:10.1007/s11538-007-9255-4 · Cited by 28
What can over 30 years of efforts to eradicate polio teach us about global health?
Alonge, O. (2020) · BMC Public Health · doi:10.1186/s12889-020-09198-z · Cited by 28
Brickley, E. B., Wieland‐Alter, W., Connor, R. I., Ackerman, M. E., Boesch, A. W., Arita, M., Weldon, W. C., O’Ryan, M., Bandyopadhyay, A. S., & Wright, P. F. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy603 · Cited by 26
Zhou, N. A., Fagnant-Sperati, C. S., Komen, E., Mwangi, B., Mukubi, J., Nyangao, J., Hassan, J., Chepkurui, A., Maina, C., van Zyl, W. B., et al. (2019) · Food and Environmental Virology · doi:10.1007/s12560-019-09412-1 · Cited by 26
Vacina contra poliomielite: um novo paradigma
Bricks, L. F. (2007) · Revista Paulista de Pediatria · doi:10.1590/s0103-05822007000200013 · Cited by 25
A quantitative survey of the literature on poliovirus infection and immunity
Behrend, M. R., Hu, H., Nigmatulina, K. R., & Eckhoff, P. A. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.09.005 · Cited by 25
Zhou, N. A., Fagnant-Sperati, C. S., Shirai, J. H., Sharif, S., Zaidi, S., Rehman, L., Hussain, J., Agha, R. D., Shaukat, S., Alam, M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200551 · Cited by 23
Alam, J., Rashid, M., Kabir, Y., Raqib, R., & Ahmad, S. M. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.10.075 · Cited by 23
Gnanashanmugam, D., Halpern, M. S., Dodge, A., Fang, M., Wong, L. J., Esparza, M., Hammon, R. J., Rivas-Merelles, E. E., Santos, J. I., & Maldonado, Y. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02268-06 · Cited by 21
Polio: Measuring the Protection That Matters Most
Fine, P. (2009) · The Journal of Infectious Diseases · doi:10.1086/605331 · Cited by 19
Determinants of monovalent oral polio vaccine mutagenesis in vaccinated elderly people
Boot, H. J., Sonsma, J. A. J., Nunen, F. J. H. B. V. A.-V., Abbink, F., Kimman, T. G., & Buisman, A. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.04.007 · Cited by 17
Manukyan, H., Zagorodnyaya, T. A., Rüttimann, R. W., Manor, Y., Bandyopadhyay, A. S., Shulman, L. M., Chumakov, K., & Laassri, M. (2018) · Journal of Virological Methods · doi:10.1016/j.jviromet.2018.06.009 · Cited by 16
Self-citationTroy, S. B., Ferreyra-Reyes, L. D., Canizales‐Quintero, S., Huang, C., Lee, Y.-J., Báez-Saldaña, R., Ferreira-Guerrero, E., García‐García, L., & Maldonado, Y. (2012) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pis062 · Cited by 15
When Can We Stop Using Oral Poliovirus Vaccine?
Hull, H. F., & Minor, P. D. (2005) · The Journal of Infectious Diseases · doi:10.1086/498171 · Cited by 14
Li, R., Li, C., Wang, H., Luo, H., Li, Y., Wang, J., Ying, Z., Yu, W., Shu, J. D., Wen, N., et al. (2015) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piv017 · Cited by 13
Mychaleckyj, J. C., Haque, R., Carmolli, M. P., Zhang, D., Colgate, E. R., Nayak, U., Taniuchi, M., Dickson, D. M., Weldon, W. C., Oberste, M. S., et al. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.11.046 · Cited by 11
What Role for Inactivated Poliovirus Vaccine in the Eradication Endgame?
Kew, O. M. (2006) · The Journal of Infectious Diseases · doi:10.1086/503373 · Cited by 11
Inactivated Polio Vaccine: its proposed role in the final stages of polio eradication
Davis, R., & Biellik, R. (2013) · Pan African Medical Journal · doi:10.11604/pamj.2013.14.102.2580 · Cited by 8
Shulman, L. M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5719-0_10 · Cited by 7
Reduced mucosal immunity to poliovirus after cessation of trivalent oral polio vaccine
Zhao, T., Li, J., Shi, H., Ye, H., Ma, R., Fu, Y., Liu, X., Li, G., Yang, X., Zhao, Z., et al. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1911213 · Cited by 7
Khardori, N. M. (2010) · Yearbook of Medicine · doi:10.1016/s0084-3873(10)79659-0 · Cited by 7
for the POG group, Yaari, R., Kaliner, E., Grotto, I., Katriel, G., Moran‐Gilad, J., Sofer, D., Mendelson, E., Miller, E., & Huppert, A. (2016) · BMC Medicine · doi:10.1186/s12916-016-0666-7 · Cited by 7
Halbrook, M. (2021) · eScholarship (California Digital Library) · Cited by 7
Fu, Y., Ma, R., Zhao, Z., Mo, Z., Ying, Z., Li, J., Ye, H., Li, G., Liu, X., Liang, J., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01134-9 · Cited by 6
Gut Immunology and Oral Vaccination
Tennant, S. M., Muhsen, K., & Pasetti, M. F. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1419-3_3 · Cited by 6
Giri, S., Kasirajan, A., Kumar, N., Dhanapal, P., Venkatesan, J., Iturriza‐Gómara, M., Taniuchi, M., John, J. K., Abraham, A. M., & Kang, G. (2017) · Journal of Medical Virology · doi:10.1002/jmv.24793 · Cited by 6
Ruhanya, V., Zhou, N. A., Berejena, C., Nyandoro, G., Chibukira, P., Mukaratirwa, A., Masunda, K., & Meschke, J. S. (2022) · Water SA · doi:10.17159/wsa/2022.v48.i3.3892 · Cited by 5
Poliovirus Vaccine—Inactivated
Vidor, E. J., & Modlin, J. F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00049-9 · Cited by 5
Shulman, L. M. (2012) · Springer eBooks · doi:10.1007/978-1-4419-0851-3_839 · Cited by 5
Estívariz, C. F., Burns, C. C., & Macklin, G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00050-5 · Cited by 4
Eriksen, H. B., Lund, N., Biering-Sørensen, S. R., Correia, C., Barbosa, A., Andersen, A., Aaby, P., Jeppesen, D. L., & Benn, C. S. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.03.082 · Cited by 4
Rao, V. U. S., Rao, U., Kunigal, S., Kannan, S., Kumar, J., & Gulia, A. (2021) · Indian Journal of Medical Sciences · doi:10.25259/ijms_176_2021 · Cited by 4
Coding Biases and Viral Fitness
Bosch, A., Mueller, S., & Pintó, R. M. (2014) · ASM Press eBooks · doi:10.1128/9781555816698.ch17 · Cited by 3
Manukyan, H., Petrovskaya, S. N., Chumakov, K., & Laassri, M. (2020) · Vaccines · doi:10.3390/vaccines8010120 · Cited by 3
Self-citationUniversal use of inactivated polio vaccine
Bricks, L. F. (2006) · Jornal de Pediatria · doi:10.1590/s0021-75572006000800016 · Cited by 3
Susanti, N., & Herna, H. (2019) · Health Science Journal of Indonesia · doi:10.22435/hsji.v10i1.1846 · Cited by 2
Xu, J., Wang, Q., Kuang, S., Rong, R., Zhang, Y., Fu, X., & Tang, W. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1868269 · Cited by 2
Manukyan, H., Tritama, E., Wahid, R., Ansari, A., Konz, J., Chumakov, K., & Laassri, M. (2021) · Vaccines · doi:10.3390/vaccines9070688 · Cited by 2
Self-citationInactivated Polio Vaccine Must Be an Essential Part of Polio Eradication
Chumakov, K., & Plotkin, S. A. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf215 · Cited by 2
Self-citationPolio eradication: inching forward, with safety nets
Kirkpatrick, B. D., & Mychaleckyj, J. C. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00261-3 · Cited by 1
Wilton, T. (2012) · doi:10.25560/10677 · Cited by 1
Fecal shedding and transmission of vaccine–derived poliovirus: A systematic review and meta–analysis
Yunus, G. M., Taher, K. A., Akram, K. A., Anil, D. S., Anis, H. S., & Shaikh, A. (2024) · One Health Bulletin · doi:10.4103/ohbl.ohbl_29_24 · Cited by 1
Modeling Vaccination Strategies for the Control and Eradication of Childhood Infectious Disease
Wagner, B. G. (2008) · MacSphere (McMaster University) · doi:10.71548/8356
Excretion of Oral Poliovirus Vaccine Strains: Effect of Vaccination Schedule
Modlin, J. F., & Halsey, N. A. (2006) · The Journal of Infectious Diseases · doi:10.1086/503815
Stochastische Modellierung von Exitstrategien der Poliomyelitis
Krampol, M. (2007)
Poliovirus shedding after the first and second doses of trivalent polio vaccines in newborns
Rusmil, V. K., Dhamayanti, M., Adi, S. S., & Megantara, I. (2015) · Paediatrica Indonesiana · doi:10.14238/pi55.4.2015.219-23
Exploration of the Mechanisms of Adjuvanticity for Toll-like Receptor Agonists
Salyer, A. C. D. (2017) · KU ScholarWorks (The University of Kansas)
Oliveira, T. G. (2018) · Americanae (AECID Library)
Investigation of the Phenyl Ring of Imidazoquinolines
Hunt, J. R. (2018) · KU ScholarWorks (The University of Kansas)
Shulman, L. M. (2020) · Springer eBooks · doi:10.1007/978-1-4939-2493-6_839-3
REVIEW ON CURRENT POLIO VACCINES: VACCINATION SCHEDULES AND ADMINISTRATION ROUTES
Kumar, V. T. A. (2019) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.2656514
Shulman, L. M. (2023) · Encyclopedia of sustainability science and technology series · doi:10.1007/978-1-0716-2463-0_839
Kapoor, S., & Kapoor, M. (2022) · D Y Patil Journal of Health Sciences · doi:10.4103/dypj.dypj_50_22
Yin, Q., Zheng, Y. P., Ying, Z., Li, J., Jiang, Y., Bao, W., Dou, Y., Pu, Y., Lei, J., Yang, H.-T., et al. (2024) · Vaccines · doi:10.3390/vaccines12020217
Singh, O., Manukyan, H., Tritama, E., Lee, S., Weir, J. P., & Laassri, M. (2025) · Vaccines · doi:10.3390/vaccines13010075
Self-citationAssessing Vaccine Effects on Infectiousness in COVID-19 Vaccine Trials
Hocter, J. (2021) · ResearchWorks at the University of Washington (University of Washington)
Metadata
- Authors
- Laassri, M., Lottenbach, K., Belshe, R., Wolff, M., Rennels, M., Plotkin, S., & Chumakov, K.
- Affiliations
- Center for Biologics Evaluation and Research (US)
- Saint Louis University (US)
- Emmes (United States) (US)
- University of Maryland, Baltimore (US)
- University of Pennsylvania (US)
- Corresponding author
- Laassri, Majid
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-12-15
- Volume
- 192
- Issue
- 12
- Pages
- 2092-2098
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2101462714
- Cited by
- 85
- References
- 28
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 5 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 3 · 2018: 7 · 2017: 3 · 2016: 1 · 2015: 7 · 2014: 4 · 2013: 6 · 2012: 10
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sanofi
- National Institutes of Health (n01ai45250-46-0-0, n01ai045251-006)
- Advanced Research Projects Agency
- Sanofi Pasteur
- National Institute of Allergy and Infectious Diseases (N01-AI45250, 45251, N0 1 AI-45251)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- oral polio vaccine, inactivated poliovirus vaccine, vaccination schedule, mucosal immunity, intestinal immunity, children, poliovirus transmission
- MeSH terms
- DNA, Viral, Feces, Humans, Immunization Schedule, Infant, Poliovirus Vaccine, Inactivated, Poliovirus Vaccine, Oral, RNA, Viral, Serotyping, Polymerase Chain Reaction, Genome, Viral, Virus Shedding, Poliovirus, DNA, Complementary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.